Pernod Ricard SA (PRNDY) Q1 2026 Sales Call Transcript

Pernod Ricard reported a 7.6% organic net sales decline for Q1 FY'26, a result the company had anticipated. This downturn was primarily attributed to significant inventory adjustments in the U.S. and a sharp sales contraction in China, driven by macroeconomic weakness, consumer sentiment, and trade inventory adjustments. Despite these factors, the company indicated that underlying performance was approximately 3 points better than the reported net sales, with strong underlying growth in India partially offset by excise policy changes in Maharashtra State.

Analysis

Pernod Ricard (PRNDY) reported a 7.6% organic net sales decline for Q1 FY'26, a result the company had anticipated and communicated previously. This significant contraction was primarily driven by expected inventory adjustments in the U.S. and a sharp sales decline in China, reflecting macroeconomic weakness and consumer sentiment. The company's tone was defensive, acknowledging the negative headline figures while emphasizing the expected nature of the downturn.

Despite the reported net sales decline, Pernod Ricard indicated that underlying performance was approximately 3 points better, suggesting a less severe operational reality once inventory effects are factored out. The U.S. saw improving sellout performance despite net sales decline, while China's contraction was attributed to macroeconomic weakness and consumer sentiment. India demonstrated strong underlying growth, though sales were negatively impacted by excise policy changes in Maharashtra State.

The anticipated nature of the Q1 decline, coupled with the better underlying performance, suggests that the company is managing expectations and facing temporary headwinds rather than a fundamental demand collapse. The market impact score of 0.6, despite strongly negative sentiment, could imply that these challenges were largely priced in or that investors are focusing on the underlying trends. However, continued macroeconomic weakness in China and regulatory risks in key markets like India remain pertinent.

Key Decisions for Investors

• Investors should closely monitor Pernod Ricard's future reports for signs of inventory normalization in the U.S. and China, as these adjustments significantly masked underlying performance in Q1.
• Given the impact of macroeconomic weakness and consumer sentiment in China, investors should track economic data from this region for potential recovery or further deterioration, which will directly influence sales.
• The negative impact of excise policy changes in India highlights regulatory risk; investors should assess the potential for similar policy shifts in other significant markets.
• While headline sales were down, the company noted better underlying performance; investors should analyze segment-specific underlying growth rates, particularly in emerging markets like India, for long-term potential.